Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: Comparative analysis of the Macdonald, RECIST, RANO, and RECIST F criteria

1. Pérez-Larraya, J.G.
2. Lahutte, M.
3. Petrirena, G.
4. Reyes-Botero, G.
5. González-Aguilar, A.
6. Houillier, C.
7. Guillevin, R.
8. Sanson, M.
9. Hoang-Xuan, K.
10. Delattre, J.-Y.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/NEUONC/NOS070 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus